| Pharmacoeconomics of levocetirizine in allergic rhinitis and chronic idiopathic urticaria: considerations for the USA. | |
| | |
MedLine Citation:
|
PMID: 20528375 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Background: Levocetirizine, a recent, second-generation oral antihistamine, was approved by the US FDA in May 2007 to treat symptoms of allergic rhinitis and chronic idiopathic urticaria. Objective: To review the economic literature for levocetirizine. Methods: Two reviewers conducted a systematic review of the literature to identify abstracts that met the inclusion criteria. Abstracts that were considered acceptable were retrieved with full text for further assessment. Results: A total of 82 potential studies were identified. After reviewing abstracts, 11 articles were preselected for potential inclusion. Of the 11 full-text articles, three articles met the inclusion criteria. Conclusion: The pharmacoeconomic literature for levocetirizine was limited. The findings were consistent across the literature, suggesting levocetirizine improved outcomes, leading to incremental cost savings and cost-effectiveness. Since many of the available levocetirizine data come from European studies, differences in practice patterns and medical resources should be considered when extrapolating data to a US clinical setting. |
| | |
Authors:
|
Lawrence M Dubuske; Brian Seal; Martin Cj Brown |
Related Documents
:
|
11914305 - Searching the literatura latino americana e do caribe em ciências da saúde (lilacs) d... 19203465 - The use of surrogate outcomes in model-based cost-effectiveness analyses: a survey of u... 11770685 - Fungi: toxic killers or unavoidable nuisances? 20424405 - Safety baseballs and chest protectors: a systematic review on the prevention of commoti... 23578155 - Inter-observer variability in the reporting of dynamic evacuation proctography. 9926685 - Problems and management of the rearfoot in neuromuscular disease. a report of ten cases. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Expert review of pharmacoeconomics & outcomes research Volume: 8 ISSN: 1744-8379 ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Publication Date: 2008 Jun |
Date Detail:
|
Created Date: 2010-06-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101132257 Medline TA: Expert Rev Pharmacoecon Outcomes Res Country: England |
Other Details:
|
Languages: eng Pagination: 233-41 Citation Subset: - |
Affiliation:
|
Consultant in Allergy, Brigham and Women's Hospital; Clinical Instructor in Medicine, Harvard Medical School, Boston, MA, USA. ldubuske@partners.org. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Gefitinib: a consideration of cost.
Next Document: NCIC Clinical Trials Group experience of employing patient-reported outcomes in clinical trials: an ...